logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Atalanta Therapeutics Appoints Joanne Kotz As Chief Executive Officer and Douglas Pagán As Chief Financial Officer & Chief Operating Officer

Jun 18, 2025•6 months ago

Position

Chief Financial Officer

Company

Atalanta Therapeutics

Douglas Pagán
BostonTherapeuticsBiotechnologyHealth Care

Description

Atalanta Therapeutics has named Joanne Kotz as Chief Executive Officer, succeeding Alicia Secor. The company also appointed Douglas Pagán as Chief Financial Officer & Chief Operating Officer, succeeding Jeffrey Young as part of a leadership transition.

Company Information

Company

Atalanta Therapeutics

Location

Boston, Massachusetts, United States

About

Atalanta Therapeutics is a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases. Their discovery efforts utilize a best-in-class di-siRNA platform and have generated a robust portfolio of 14 current programs across their wholly-owned and partnered pipelines.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months